02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
23/11/2022

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology.
11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

11/10/2022

Factsheet – Vision for Europe: Excellence

11/10/2022

Factsheet – Vision for Europe: Investment

11/10/2022

Factsheet – Vision for Europe: Innovation

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum

03/10/2022

Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio

30/09/2022

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe

21/09/2022

Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia

21/09/2022

Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics